The Binding Site

The Binding Site The Specialist Protein Company

Binding Site, Part of Thermo Fisher Scientific, is committed to improving patient lives worldwide through education, collaboration and innovation. Binding Site provide diagnostic solutions that help doctors, clinicians and laboratory researchers across the globe diagnose and monitor blood cancers and immune system disorders. Founded by researchers at the University of Birmingham, Binding Site has continued to build on its strong scientific foundations, supporting research and development within our field and responding to the changing needs of patients, researchers and clinicians for over 30 years. We are committed to working in collaboration with our partners and customers to lead the way in specialized medical diagnostics, ensuring we continue to make a difference together.

13/03/2026

This week at The Binding Site, we came together to celebrate International Women’s Day 2026 with a panel discussion inspired by this year’s theme, recognising the power of generosity, mentorship and allyship in accelerating gender equality.

Thank you to our fantastic panel: Tantoo Fox (Host), Maggie Pochyla, Parvin Virdee, Rachael Brown and Kara Gilks, who shared their experiences, insights and perspectives on leadership, opportunity and growth. The conversation highlighted how giving our time, knowledge and support not only opens doors for others, but strengthens us all.

We are proud to have many exceptional women contributing to our growth and success. Our Women’s Empowerment Business Resource Group (WEBRG), part of Thermo Fisher Scientific, is dedicated to fostering diversity and inclusion, creating a global environment that embraces and values the unique qualities and differences of all our employees.

Watch our video to hear from the inspiring individuals across our business who make The Binding Site what it is today.

Most people with Multiple Myeloma experience symptoms before diagnosis. These can be mistaken for those of other, more c...
11/03/2026

Most people with Multiple Myeloma experience symptoms before diagnosis. These can be mistaken for those of other, more common conditions, so they are often overlooked .

If symptoms persist or worsen, speaking to a healthcare professional is important.

This Myeloma Action Month, we’re encouraging greater awareness of the early signs of myeloma.

Learn more about myeloma diagnosis and early detection: https://www.thermofisher.com/bindingsite/wo/en/expert-insights/multiple-myeloma-diagnosis-criteria.html?cid=0so_lnk_25022026_W20FGT

Multiple Myeloma is the second most common blood cancer worldwide, after lymphoma. It develops in plasma cells, a type o...
09/03/2026

Multiple Myeloma is the second most common blood cancer worldwide, after lymphoma.

It develops in plasma cells, a type of white blood cell found in the bone marrow, and can affect bones, kidneys, blood counts, and immune function.

Despite being one of the most common blood cancers, awareness remains low.

This Myeloma Action Month, we’re helping shine a light on the signs, symptoms, and impact of this disease. Learn more: http://spr.ly/6187hsOdP

Turning awareness into action means understanding precursor diseases. Monoclonal gammopathy of undetermined significance...
09/03/2026

Turning awareness into action means understanding precursor diseases. Monoclonal gammopathy of undetermined significance (MGUS) is a common precursor to multiple myeloma, but most patients with MGUS will not progress to myeloma. Understanding MGUS and evaluating patients at risk of progression is an important part of early detection. This Multiple Myeloma Action Month, we're raising awareness of the link between MGUS and myeloma, and the importance of appropriate follow-up. Awareness of precursors leads to proactive action.

Read our recent blog to learn more about MGUS: http://spr.ly/6181h25oT

This Multiple Myeloma Action Month, join us for an on-demand educational webinar addressing diagnostic delays in multipl...
05/03/2026

This Multiple Myeloma Action Month, join us for an on-demand educational webinar addressing diagnostic delays in multiple myeloma. Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, shares actionable insights for primary care providers on recognizing symptoms, understanding diagnostic challenges, addressing health disparities, and selecting the right tests for accurate diagnosis.

Watch the webinar: http://spr.ly/6188h25GO

1 in 5 people diagnosed with Multiple Myeloma in the United States is African American African Americans are disproporti...
05/03/2026

1 in 5 people diagnosed with Multiple Myeloma in the United States is African American

African Americans are disproportionately affected by Multiple Myeloma and often face worse outcomes .

Raising awareness of this disparity is critical to driving earlier recognition, equitable access to care, and better support for patients and families.

Learn more about the other populations at higher risk of developing myeloma here: https://www.thermofisher.com/bindingsite/wo/en/expert-insights/multiple-myeloma-signs-for-referral.html?cid=0so_fbk_25022026_3BZFDT

This March is Multiple Myeloma Action Month, a time to turn awareness into action. Multiple myeloma is often diagnosed l...
03/03/2026

This March is Multiple Myeloma Action Month, a time to turn awareness into action. Multiple myeloma is often diagnosed late, after months of non-specific symptoms and multiple doctor visits. Early signs are easy to miss, and incomplete testing can delay diagnosis.

This month, we're focusing on what matters most: recognizing the signs early, ordering the right tests, and acting decisively. Because in multiple myeloma, early action can improve outcomes.

Download our infographic to learn more: http://spr.ly/6184h4eTn

How can you support Myeloma Action Month? Help us and the by raising awareness of myeloma .Greater awareness can lead ...
02/03/2026

How can you support Myeloma Action Month?

Help us and the by raising awareness of myeloma .

Greater awareness can lead to earlier conversations, earlier testing, and earlier support.

This March, join the global community in shining a light on Multiple Myeloma and the people at the heart of every story.

Learn how you raise awareness and show support here: http://spr.ly/6180hs3Jg

Today marks the start of Myeloma Action Month. Its theme is that there is for patients living with this disease. Myelom...
01/03/2026

Today marks the start of Myeloma Action Month. Its theme is that there is
for patients living with this disease.

Myeloma impacts patients, families, clinicians and laboratory teams every day.

Each year we stand alongside the International Myeloma Foundation supporting their campaign to increase the awareness of myeloma and the importance of an early diagnosis.

Learn more 👉 http://spr.ly/6189hsO9W

Did you know? Rare diseases affect over 300 million people worldwide. Early and accurate diagnosis can significantly cha...
28/02/2026

Did you know? Rare diseases affect over 300 million people worldwide. Early and accurate diagnosis can significantly change a patient’s journey.

Here at The Binding Site, we are committed to advancing specialty diagnostics that support earlier detection and informed clinical decisions.

On , we reaffirm our commitment to encouraging early detection, support ongoing research and provide crucial information to aid clinicians to make a difference where it matters most.

27/02/2026

A new publication from the Spanish Society of Laboratory Medicine (SEMEDLAB) and the Spanish Society of Hematology (SEHH) highlight the value of MALDI-TOF mass spectrometry assessment in patients with monoclonal gammopathies.

These recommendations reinforce MALDI-TOF MS as a routine-ready solution supporting greater confidence in diagnosis and long-term patient monitoring.

Hear from hematologist Dr Noemí Puig on the importance of these guidelines: http://spr.ly/6188htO2r

Address

8 Calthorpe Road, Edgbaston
Birmingham
B151QT

Opening Hours

Monday 7:30am - 5pm
Tuesday 7:30am - 5pm
Wednesday 7:30am - 5pm
Thursday 7:30am - 5pm
Friday 7:30am - 5pm

Telephone

+441214569500

Website

Alerts

Be the first to know and let us send you an email when The Binding Site posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Binding Site:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category